Dow Up0.09% Nasdaq Down0.02%

More On ASTRAZEN.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


AstraZeneca Pharma India Limited (ASTRAZEN.NS)

-NSE
978.50 Down 2.05(0.21%) 6:00AM EDT
ProfileGet Profile for:
AstraZeneca Pharma India Limited
Avishkar
Post box No. 2483
Bengaluru, 560024
India - Map
Phone: 91 80 6774 8000
Fax: 91 80 2362 2015
Website: http://www.astrazenecaindia.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

AstraZeneca Pharma India Limited engages in the manufacture, distribution, and marketing of pharmaceutical products in India and internationally. It operates in three segments: Healthcare, Clinical Trial Services, and Co-promotional Services. The company primarily provides products in the areas of cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation healthcare. Its products include Betaloc, Seloken XL, Imdur, Crestor, Seloram, Vigocil, Vigocil M, Nitract SR, Valfect,Olways, Olways H, Olways AM for cardiovascular diseases; and Onglyza, Kombiglyze XR, and Byetta for diabetes. The company also offers Mit’s Linctus Codeinae Co, Mit’s Linctus DX, Bricarex, Bricarex A, Bricacef, Bricacef PED, Bricanyl Syrup, and Symbicort for respiratory diseases; Prostodin, Cerviprime, and Partocin for maternal healthcare; Arimidex, Nolvadex, Iressa, Zoladex, Casodex, and Faslodex for oncology; and Meronem, Vancocin CP, Enclere, and Remergin for infections. In addition, it provides Xylocaine, Sensorcaine, Diprivan, and Naropin for neuroscience; and Neksium tablets and injections for gastrointestinal diseases. The company was incorporated in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on AstraZeneca Pharma India Limited

Key Executives 
 PayExercised
Ms. Ruby Lau , 43
VP of Operations
6.67MN/A
Mr. Robert Ian Haxton , 45
Whole-Time Director and Member of Share Transfer Committee
4.93MN/A
Mr. Sanjay Murdeshwar , 48
Managing Director, Director, Member of Share Transfer Committee and Member of Shareholders'/Investors' Grievance Committee
N/AN/A
Mr. Rajesh Marwaha , 51
Chief Financial Officer
N/AN/A
Mr. Ramesh Kadaba Venkatapathi , 62
Director of Quality Assurance & Technical Services
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.